Clinical trial
Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia
NCT02807142 is registered in ClinicalTrials.gov with Puerta de Hierro University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia
- Lead sponsor
- Puerta de Hierro University Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- February 7, 2018
- Enrollment
- 6 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
post-traumatic syringomyelia